These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 128269)
1. [Interrelationships between serum and secretory antibodies in immunization with live influenza vaccine]. Shvartsman IaS; Krylov VA; Agranovskaia EN; Mal'tseva AI Zh Mikrobiol Epidemiol Immunobiol; 1975 Aug; (8):35-8. PubMed ID: 128269 [TBL] [Abstract][Full Text] [Related]
2. Formation of secretory and circulating antibodies after immunization with live and inactivated influenza virus vaccines. Shvartsman YS; Agranovskaya EN; Zykov MP J Infect Dis; 1977 May; 135(5):697-705. PubMed ID: 858947 [TBL] [Abstract][Full Text] [Related]
3. Secretory immune response after nasal vaccination with live attenuated influenza viruses. Crifö S; Vella S; Filiaci F; Resta S; Rocchi G Rhinology; 1980 Jun; 18(2):87-92. PubMed ID: 7403787 [TBL] [Abstract][Full Text] [Related]
4. [Importance of secretory antibodies in nonsusceptibility to influenza B disease and the prevention of the spread of this virus]. Tsybul'skaia NV; Popova TL; Ispolatova AV; Tsybalova LM; Oleĭnikova EV Zh Mikrobiol Epidemiol Immunobiol; 1983 Jul; (7):81-3. PubMed ID: 6226166 [TBL] [Abstract][Full Text] [Related]
5. Immunization against influenza in humans using an oral enteric-coated killed virus vaccine. Lazzell V; Waldman RH; Rose C; Khakoo R; Jacknowitz A; Howard S J Biol Stand; 1984 Jul; 12(3):315-21. PubMed ID: 6480615 [TBL] [Abstract][Full Text] [Related]
6. Immunity following intranasal administration of an inactivated, freeze-dried A/England/42/72 vaccine. Potter CW; Jennings R; McLaren C; Clarke A Arch Virol; 1975; 48(4):307-16. PubMed ID: 1200844 [TBL] [Abstract][Full Text] [Related]
7. [The use of saliva for study in the immunoenzyme analysis of postvaccinal and postinfectious immunity to influenza]. Naĭkhin AN; Mikhaĭlov AA; Kustikova IuG; Tsybalova LM; Klimovich VB; Artem'eva SA; Krasheniuk AI; Katorgina LG; Kim TN; Denisov GM Vopr Virusol; 1993; 38(5):201-4. PubMed ID: 8284915 [TBL] [Abstract][Full Text] [Related]
8. [Dynamics of the specific antibodies in persons with unaltered palatine tonsils, in chronic tonsillitis and in persons with the tonsils removed immunized with a live influenza vaccine]. Gorbachevskiĭ VN Zh Ushn Nos Gorl Bolezn; 1978; (1):67-74. PubMed ID: 636625 [No Abstract] [Full Text] [Related]
9. [Experience in using the HIR modified by the addition of antisera to IgG, IgM and IgA for detecting anti-influenzal antibodies in respiratory tract discharge]. Gennad'eva TIa; Khazenson LB; Bichurina MA Tr Inst Im Pastera; 1976; 47():78-84. PubMed ID: 1052587 [No Abstract] [Full Text] [Related]
10. The sequential appearance of antibody and immunoglobins in nasal secretion after immunization of volunteers with live and inactivated influenza B virus vaccines. Downie JC J Hyg (Lond); 1973 Sep; 71(3):433-45. PubMed ID: 4518342 [TBL] [Abstract][Full Text] [Related]
11. Antibody in tears, saliva and nasal secretions following oral immunization of humans with inactivated influenza virus vaccine. Bergmann KC; Waldman RH; Tischner H; Pohl WD Int Arch Allergy Appl Immunol; 1986; 80(1):107-9. PubMed ID: 3957442 [TBL] [Abstract][Full Text] [Related]
13. [Secretory immunity in persons inoculated with killed influenza vaccine purified and concentrated on silicate sorbents]. Bichurina MA Tr Inst Im Pastera; 1976; 47():134-40. PubMed ID: 210539 [No Abstract] [Full Text] [Related]
14. [Participation of secretory antibodies in the protection from influenza]. Shvartsman IaS; Agranovskaia EN; Grigor'eva SK; Mal'tseva AI; Koval' TA Zh Mikrobiol Epidemiol Immunobiol; 1977 Sep; (9):53-6. PubMed ID: 596024 [TBL] [Abstract][Full Text] [Related]
15. Reduced infectivity of cold-adapted influenza A H1N1 viruses in the elderly: correlation with serum and local antibodies. Powers DC; Murphy BR; Fries LF; Adler WH; Clements ML J Am Geriatr Soc; 1992 Feb; 40(2):163-7. PubMed ID: 1740601 [TBL] [Abstract][Full Text] [Related]
16. Neutralizing influenza antibodies, IgA and total protein in the nasopharyngeal secretions of subjects vaccinated by nasal route with the inactivated influenza vaccine prepared in the "Stefan S. Nicolau" Institute of Virology. Petrescu A; Mihail A; Samuel I; Teodosiu O; Isaia G; Ganea E; Motaş C Virologie; 1979; 30(2):109-15. PubMed ID: 111408 [TBL] [Abstract][Full Text] [Related]
17. Specificity of the local secretory antibody to influenza A virus infection. Richman DD; Murphy BR; Tierney EL; Chanock RM J Immunol; 1974 Nov; 113(5):1654-6. PubMed ID: 4213978 [No Abstract] [Full Text] [Related]
19. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine. Fedson DS; Fulk RV; Huber MA; Reisberg MA; Kasel JA J Immunol; 1971 Sep; 107(3):730-7. PubMed ID: 4999093 [No Abstract] [Full Text] [Related]
20. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine. Greenbaum E; Engelhard D; Levy R; Schlezinger M; Morag A; Zakay-Rones Z Vaccine; 2004 Jun; 22(20):2566-77. PubMed ID: 15193382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]